A Two-part, Phase I, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Tolerability and Immunogenicity of a Dose Range og Group B Streptococcus Vaccine in Healthy Female Volunteers Aged 18 to 40.
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2017
At a glance
- Drugs GBS NN (Primary) ; Aluminium hydroxide
- Indications Streptococcal infections
- Focus Adverse reactions
- Sponsors Minervax
- 01 Nov 2017 Planned End Date changed from 1 Mar 2018 to 21 Apr 2017.
- 01 Nov 2017 Planned primary completion date changed from 1 Mar 2016 to 12 Apr 2017.
- 15 Sep 2016 Status changed from recruiting to completed.